• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
?
-

Resources for You

FDA Webinar: Webinar Draft GFI On Rheumatoid Arthritis - Developing Drug Products For Treatment; Availability – July 25, 2013

On July 25, 2013, FDA presented a webinar on a new draft guidance entitled "Draft Guidance For Industry On Rheumatoid Arthritis - Developing Drug Products For Treatment; Availability."

 
The webinar provided an opportunity to learn about the guidance from individuals involved in its preparation. It was also intended to encourage the submission of questions or comments while the guidance is still in draft form.
 
Questions may be submitted to docket so that they can be formally processed by FDA.
 
DRAFT GFI:
 
FR NOTICE
 
Date FR NOA: 05/31/2013
Comment Period Closes: 07/30/2013
 
CONTACTS:
Nikolay Nikolov, MD
Medical Officer
Division Of Pulmonary, Allergy, And Rheumatology Products
Center for Drug Evaluation and Research (CDER)
White Oak, Bldg 22, Room 3335
301-796-5281
-

Presentation Information

-

Archive of Past Webinars: http://www.fda.gov/Training/GuidanceWebinars/default.htm   

 
If you have never attended a Connect Pro meeting before, please test your connection before the lecture by following this link: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm